Here’s why this award is significant: 1. Recognition of Scientific Excellence This award highlights researchers or organizations that have made outstanding contributions to innovation in genomic or transcriptomic sequencing. Technologies [...]
Article in D Magazine The Frisco Physician Growing Hypo-Allergenic Peanuts Ayass Bioscience made headlines during COVID with an advanced lab and has now turned its molecular medicine expertise to preventing [...]
If you're in search of answers regarding your specific medical condition and the best treatment options available for your unique physiology, you've found the right place. [...]
Using Transcriptome to Accurate Disease Diagnosis, Prognosis, Severity, Treatment, and Adverse Reaction Prediction The identification of biomarkers plays a crucial role in assessing disease accuracy. Transcriptome biomarkers (gene expression [...]
Published: 30 December 2022 Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease Contributors: Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, [...]
We need donors that are 18 and older to establish the ranges for a new assay to detect 65 cytokines from serum samples. The assay is one of a kind [...]
Ayass BioScience, LLC participated in Annual Meeting of The American Association of Immunologists in Oregon Convention Center Portland, Oregon, May 6-10 2022.
The Ayass Bioscience family is celebrating its sixth anniversary this year. The company has grown over the years from the dreams of our founder and CEO, Dr. Ayass, into one [...]
Testing for COVID-19 has gone up significantly in the last month, and consequently positive cases have risen as well and more Omicron variants were identified at our laboratory. Given the [...]
The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
